Skip to main content

Two-year sanction handed to Ice-Hockey athlete

Sport Integrity Australia acknowledges Ice Hockey Australia has imposed a two-year period of Ineligibility on athlete Ty Wishart

News and Media

Published

Sport Integrity Australia acknowledges that Ice Hockey Australia has imposed a two-year period of Ineligibility on athlete Ty Wishart for the Anti-Doping Rule Violation (ADRV) of Presence of a Prohibited Substance or its metabolite.

Mr Wishart returned an Adverse Analytical Finding from an In-Competition doping control test on 13 June 2025. 

Mr Wishart’s sample was analysed at the Australian Sports Drug Testing Laboratory, part of the National Measurement Institute, and the presence of D-Amfetamine, was detected.

D-Amfetamine is listed under Class S6.A (Non-Specified Stimulants) of the World Anti-Doping Code – International Standard – Prohibited List 2025. 

D-Amfetamine is classed as a Non-Specified Substance and prohibited In-Competition only.

Mr Wishart was subject to a mandatory Provisional Suspension from 1 December 2025.


 

Our latest news, resources, podcasts, courses and webinars:

 

SUBSCRIBE FOR UPDATES

 

In accordance with Article 10.2.1 of the Australian National Anti-doping Policy 2021 (ANADP), Mr Wishart established that the ADRV was not intentional.

Accordingly, Ice Hockey Australia has imposed a two-year period of Ineligibility commencing on 1 September 2025, backdated by three months from the date of his mandatory Provisional Suspension for delays not attributable to the Athlete.

In accordance with Articles 10.1 and 10.10 of the ANADP, any medals, points or prizes obtained by Mr Wishart from 13 June 2025 onwards, will be forfeited.

Mr Wishart is ineligible to participate in any sports that have adopted a World Anti-Doping Code compliant anti-doping policy until 11:59pm 31 August 2027.

He is also not permitted to compete in a non-signatory professional league, or event organised by a non-signatory International or National level event organisation.

Additional information on the Prohibited Substance

D-Amfetamine is a stimulant drug commonly used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

Stimulant medications, such as Methylphenidate (for example Ritalin, Concerta), Dexamphetamine and D-Amfetamine/Dextroamfetamine (for example Vyvanse) are prohibited In-Competition and require a Therapeutic Use Exemption (TUE).

  • Sport Integrity Australia recommends you check all your substances before you take them on the Sport Integrity App.